Loading...

DERM JOURNEY MEDICAL CORP Product Launches 8-K Filing

JRNY

DRM

JOURNEY MEDICAL CORP

(DERM)

2025 8-K

Show Summary

Summary

Stock Offering Agreement

Product Expansion

Market Expansion

Financial Statements

Management Change

Financial Results

Financial Update

Financial Results

Financial Results

Financial Results

Amendment to Credit Agreement

Departure of Directors or C...

Earnings Reports

Appointment of CFO

Earnings Reports

Credit Agreement for Term L...

Resignation of Director

Earnings Reports

Compliance Notification and...

Compliance and License Agre...

Earnings Reports

Annual Meeting Approval

Loan Agreement Amendment

Earnings Reports

Management Change

Sales Agreement

External Links:

On March 24, 2025, Journey Medical Corporation launched Emrosi, a new medication for treating rosacea, and filled its first prescriptions.

AI Assistant

JOURNEY MEDICAL CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.